Loading the section…
The price of Sol-Gel Technologies Ltd. (SLGL) on October 9, 2026 is 71.77 USD, +2.03% on the day. Over 52 weeks the stock traded between 28.81 USD and 97.97 USD; the price now sits 62% of the way up that range. Over the past year the price changed by +82.53%.
Closing prices for 9 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Change over the period shown (line colour): +79.65 %
Sol-Gel Technologies Ltd. trades on Nasdaq under the ticker SLGL. The company belongs to the Health care sector. The trading history on this page starts on 1 February 2018.
Over the past 52 weeks SLGL has traded between 28.81 $ and 97.97 $. As of 9 October 2026 the price stood 62.12 % of the way from the 52-week low to the high.
Over one year SLGL shares rose 82.53 %; over six months they fell 4.13 %. Volatility over 90 days is 66.34 %. Dividends are not included: this is price change only, as of 9 October 2026.
Sol-Gel Technologies Ltd. reported revenue of 19M $ and a net loss of 6M $ for the latest fiscal year. Net margin is −31.60 %. Revenue changed by +68.04 % year over year. Earnings per share are −2.19 $.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 69.85 | 72.37 | 68.78 | 71.77 | 31,500 |
| 8 October 2026 | 70.46 | 70.92 | 66.52 | 70.34 | 41,000 |
| 7 October 2026 | 74.97 | 75.07 | 71.28 | 71.95 | 31,300 |
| 6 October 2026 | 78.95 | 79.50 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
No events for this security recently.
Address:7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA, 7403648
SLGL has a return on equity of −26.86 %, above the sector median of −41.68 %. Return on assets is −20.48 %, above the sector median of −32.11 %. Operating margin is −38.88 %, below the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 73.95 |
| 75.64 |
| 44,000 |
| 5 October 2026 | 71.20 | 79.01 | 71.20 | 78.95 | 29,200 |
| 2 October 2026 | 72.88 | 74.35 | 70.84 | 72.00 | 44,400 |
| 1 October 2026 | 74.42 | 74.42 | 70.75 | 73.00 | 32,800 |
| 30 September 2026 | 73.33 | 77.67 | 72.87 | 74.28 | 39,200 |
| 29 September 2026 | 69.96 | 72.79 | 69.20 | 72.25 | 30,700 |
| 28 September 2026 | 66.72 | 72.00 | 66.72 | 69.45 | 58,000 |
| 25 September 2026 | 61.25 | 67.29 | 61.05 | 66.85 | 26,100 |
| 24 September 2026 | 59.57 | 62.63 | 58.42 | 60.74 | 66,900 |
| 23 September 2026 | 61.00 | 61.77 | 58.73 | 59.71 | 70,700 |
| 22 September 2026 | 58.79 | 63.70 | 58.79 | 60.95 | 79,700 |
| 21 September 2026 | 59.83 | 60.00 | 58.30 | 59.28 | 29,800 |
| 18 September 2026 | 64.17 | 64.61 | 60.00 | 60.00 | 45,800 |
| 17 September 2026 | 62.65 | 65.44 | 62.64 | 64.54 | 45,100 |
| 16 September 2026 | 64.46 | 64.46 | 60.98 | 63.44 | 54,500 |
| 15 September 2026 | 64.25 | 66.50 | 64.00 | 64.40 | 59,100 |
| 14 September 2026 | 65.69 | 66.39 | 64.02 | 65.18 | 27,900 |